Research programme: chitosan-encapsulated biological molecules - AdvancellAlternative Names: ADVP 1; ADVP 2; ADVP 3; ADVP 4; ADVP 5; ADVP 6; ATH 003; ATH 006; ATH 007
Latest Information Update: 20 Apr 2012
At a glance
- Originator AdvanCell
- Class Peptide hormones; Polysaccharides
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants; Thrombin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Diabetes mellitus; Thrombosis
Most Recent Events
- 20 Apr 2012 Early research in Diabetes mellitus & Thrombosis is ongoing in Spain